News | February 27, 2025
Zydus Lifesciences to launch protection against new strain of influenza virus
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives
The observations issued are neither repeated observations nor related to data integrity
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
Collaborates with VisionSpring to conduct eye check-up camps for underprivileged children
Around 100 million people live with COPD in China, accounting for almost 25% of all COPD cases globally
YESINTEK, is intended for the treatment of adults and children with plaque psoriasis and adults with psoriatic arthritis or Crohn's disease
Dr. Prabhavathi brings over 14 years of unparalleled experience in pediatrics and a specialized focus on neurodevelopmental disorders
No safety signals related to the vaccine candidate were identified
The safety profile of Opdualag observed in this analysis was consistent with the known profiles of nivolumab and relatlimab
The company will offer end-to-end services and solutions for the sector with a specific focus on sustainability
Subscribe To Our Newsletter & Stay Updated
